NTRR — NEUTRA CORP.
—
OTC ·
Materials ·
Chemicals ·
CIK 1512886 ·
Last close
—
Market Cap
—
52W High
—
52W Low
—
ADV30
—
Next earnings
—
Quarterly Fundamentals
Revenues vs Net Income (last 4 Q)
Assets vs Liabilities (last 4 Q)
| Period | Revenues | Gross profit | Op income | Net income | Assets | Cash | Liabilities |
|---|---|---|---|---|---|---|---|
| Oct 2023 | 1,311 | 589 | -52,728 | -54,986 | 26,944 | 692 | 962,984 |
| Jul 2023 | 4,325 | 1,682 | -71,769 | -71,847 | 36,942 | 1,134 | 917,996 |
| Apr 2023 | 5,842 | 2,804 | -71,208 | -71,996 | 54,104 | 3,138 | 863,311 |
| Oct 2022 | 23,383 | 10,675 | -66,074 | -81,792 | 97,963 | 456 | 1,301,515 |
Yahoo Snapshot (yfinance, live)
Total Revenue
$66,067
EBITDA
$-144,129
Free Cash Flow
$118,067
Enterprise Value
$501,765
Total Cash
$333
Total Debt
$12,314
Shares Out
2,917,899,124
Trailing EPS
$0.00
Book Value
$0.00
ROE
—
ROA
-398.3%
Div Yield
—
Annual Trend (SEC EDGAR, last 3y)
Revenues vs Net Income (last 3y)
| FY end | Revenues | Op income | Net income | Assets | Liabilities | Equity | Op cash flow |
|---|---|---|---|---|---|---|---|
| Jan 2024 | 39,534 | -229,486 | -233,465 | 2,851 | 973,529 | -970,678 | -10,337 |
| Jan 2023 | 67,996 | -297,675 | -561,417 | 75,175 | 813,795 | -738,620 | -153,243 |
| Jan 2022 | 92,014 | -583,582 | -632,926 | 130,932 | 1,153,964 | -1,023,032 | -405,615 |
TTM Snapshot
Revenues TTM
$17,397
NetIncome TTM
$-473,832
OpCashFlow TTM
—
Assets (Latest)
$26,944
Forward EPS
—
Peers — same industry
| Ticker | Name | Market Cap | Last | Daily % |
|---|---|---|---|---|
| PG | PROCTER & GAMBLE Co | $349.77B | $150.59 | — |
| LIN | LINDE PLC | $222.05B | $481.70 | — |
| UL | UNILEVER PLC | $133.37B | $61.94 | — |
| ECL | ECOLAB INC. | $78.97B | $281.69 | — |
| CL | COLGATE PALMOLIVE CO | $70.23B | $88.10 | — |
News headlines (Yahoo Finance, 1h cache)
Neutra Corp's Neutra Life Sciences Expands 2026 Industry Conference Schedule to Deepen Sponsor and CRO Relationships Across Its Site Network
2026-09-14 19:40 · Yahoo
Neutra Corp Targets Expanded Sponsor and CRO Relationships in Q3 & Q4 2026, Reaffirming Full Commitment to Life Sciences Growth
2026-07-13 17:02 · Yahoo
Neutra Corp’s Subsidiary Neutra Life Sciences Executes New Women’s Health Joint Venture and Expands Trial Portfolio
2026-06-29 19:29 · Yahoo
Neutra Corp Successfully Pivots Into New Business Vertical With Projected Over 1,000% Revenue Increase Year-Over-Year
2026-01-19 12:00 · Yahoo
Neutra Corp's Subsidiary, Neutra Life Sciences, Adds to Its Site Network With New Joint Venture Partnership in Family Medicine
2025-10-13 11:00 · Yahoo
Recent Insider Activity
No insider activity indexed for this ticker.